The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / U.S. Launches Opioid Fraud and Detection Unit

U.S. Launches Opioid Fraud and Detection Unit

August 2, 2017 • By Sarah N. Lynch

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters)—U.S. Attorney General Jeff Sessions unveiled on Wednesday a plan to go after doctors and pharmacies suspected of healthcare fraud by over-prescribing and unbridled distribution of addictive pain medications known as opioids.

You Might Also Like
  • U.S. Senator Launches Probe into 5 Top Opioid Drugmakers
  • New Fraud Detection Probes by Medicare
  • Wal-Mart Launches Program to Safely Dispose of Unused Opioids
Also By This Author
  • Maryland Judge to Weigh Obamacare Case

In a speech at a Columbus, Ohio, police academy, Sessions said a new Opioid Fraud and Abuse Detection Unit pilot program would also study death rates of patients with opioid prescriptions.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“With these new resources, we will be better positioned to identify, prosecute and convict some of the individuals contributing to these tens of thousands of deaths a year,” Sessions said in prepared remarks.

He said the new program would pay for 12 assistant U.S. attorneys serving three-year terms to investigate and prosecute fraud in the prescribing of opioids.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Deaths from opioids have surged in the United States.

In 2015, prescription painkillers and heroin killed more than 33,000 people, according to the U.S. Centers for Disease Control and Prevention. Nearly half of those overdoses involved prescription pain medications.

Sessions has made a priority of fighting drug-related crimes since taking over the U.S. Justice Department in February. It shut down AlphaBay, a dark web marketplace accused of facilitating a global trade in drugs as well as firearms and computer hacking tools.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

 

Filed Under: Drug Updates, Legal Tagged With: healthcare fraud, opioid crisis, Opioid Fraud and Abuse Detection Unit, prescription painkillers

You Might Also Like:
  • U.S. Senator Launches Probe into 5 Top Opioid Drugmakers
  • New Fraud Detection Probes by Medicare
  • Wal-Mart Launches Program to Safely Dispose of Unused Opioids
  • FDA Says It Requires Boxed Warning on Some Opioid-Based Painkillers

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)